Literature DB >> 25096587

[Immune diagnostics in rheumatology].

R Gruber1, S Borgmann.   

Abstract

Laboratory diagnostics play a fundamental role in rheumatology but must always be interpreted in the context of symptoms and clinical signs. Laboratory tests have a variety of purposes, such as confirmation or negation of a diagnosis, differential diagnosis, evaluation of activity and prognosis, involvement of organs and drug side effects. Markers of inflammation and specific autoantibodies are the most important laboratory parameters in rheumatology. Thus, with the suspicion of rheumatoid arthritis the analysis of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), the rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP or ACPA) should be performed as the first line tests. Only a few antibody titers are suitable for monitoring of disease activity. Some autoantibodies exhibit such a high diagnostic value that the antibodies are included in the classification criteria or in the definition of a disease entity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25096587     DOI: 10.1007/s00393-014-1393-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  16 in total

1.  [Early axial spondyloarthritis. Diagnostic approach and screening].

Authors:  D Poddubnyy; M Rudwaleit; J Sieper
Journal:  Z Rheumatol       Date:  2012-01       Impact factor: 1.372

2.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

Review 3.  Biological and clinical effects of anti-TNFalpha treatment.

Authors:  G Valesini; C Iannuccelli; E Marocchi; L Pascoli; V Scalzi; M Di Franco
Journal:  Autoimmun Rev       Date:  2007-03-26       Impact factor: 9.754

4.  International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Nancy Agmon-Levin; Jan Damoiseaux; Cees Kallenberg; Ulrich Sack; Torsten Witte; Manfred Herold; Xavier Bossuyt; Lucille Musset; Ricard Cervera; Aresio Plaza-Lopez; Carlos Dias; Maria José Sousa; Antonella Radice; Catharina Eriksson; Olof Hultgren; Markku Viander; Munther Khamashta; Stephan Regenass; Luis Eduardo Coelho Andrade; Allan Wiik; Angela Tincani; Johan Rönnelid; Donald B Bloch; Marvin J Fritzler; Edward K L Chan; I Garcia-De La Torre; Konstantin N Konstantinov; Robert Lahita; Merlin Wilson; Olli Vainio; Nicole Fabien; Renato Alberto Sinico; Pierluigi Meroni; Yehuda Shoenfeld
Journal:  Ann Rheum Dis       Date:  2013-10-14       Impact factor: 19.103

Review 5.  Laboratory diagnosis of rheumatoid arthritis.

Authors:  Eugene Farng; Jeffrey Barton Friedrich
Journal:  J Hand Surg Am       Date:  2011-04-02       Impact factor: 2.230

6.  High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.

Authors:  N Firooz; D A Albert; D J Wallace; M Ishimori; D Berel; M H Weisman
Journal:  Lupus       Date:  2011-03-24       Impact factor: 2.911

7.  [Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) : solo or duet?].

Authors:  J G Kuipers; L Köhler
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

Review 8.  Profiling of rheumatoid arthritis associated autoantibodies.

Authors:  Karsten Conrad; Dirk Roggenbuck; Dirk Reinhold; Thomas Dörner
Journal:  Autoimmun Rev       Date:  2009-11-28       Impact factor: 9.754

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

Review 10.  Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations.

Authors:  Dimitrios Vassilopoulos; Leonard H Calabrese
Journal:  Arthritis Res Ther       Date:  2008-09-18       Impact factor: 5.156

View more
  1 in total

Review 1.  [Differentiated laboratory diagnostics of rheumatic diseases].

Authors:  C Specker
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.